Welcome Message

On behalf of the organizing committee, I would like to welcome you to the 9th edition of Antibody Therapeutic Conference (ATC) - 2022 Antibody Therapeutics Conference: Extended Application of Antibody, which will be held in the National Biotechnology Research Park (Taipei, Taiwan) on Nov 15th.

The application of antibody therapeutics remains a growing research area today, especially in the treatment for cancers, immune-mediated diseases and infectious diseases. Particularly, immunotherapies including antibody-mediated tumor regression, checkpoint blockade, antibody drug conjugates (ADC) and Chimeric antigen receptor T-cell therapy (CAR-T) are regarded as potential strategies to cure cancers.

To showcase a broad scope of remarkable achievements, this year the Antibody Therapeutics Conference (ATC) will focus on the extended application of antibody.

Taiwan Antibody Association(TAA), the ATC organizer, was establishment back in 2012 with the mission to facilitate the research and industrial development of antibody drugs and related technologies in Taiwan. By hosting international conference, we aim to provide a platform for the attendees to connect and communicate, along with opportunities for students, postdoctoral fellows and other participants in the field to learn new knowledge and join discussion.

Last but not least, we hope this conference is able to stimulate interactions between senior experts and young scientists working on antibody therapeutics. We sincerely hope this annual event will contribute to the advancement of antibody therapeutics and you will find it informative, insightful and inspiring.